Premium Compounded GLP-1 Medication direct from FDA-Licensed Drug Manufacturer!
Ozempic®
(Semaglutide) Injection: Ozempic® is a brand-name version of the generic medication semaglutide, which is a type of medication called a GLP-1.
- A weekly shot to lose weight
- Helps you feel full faster, longer
- Improves the way your body responds to sugars
- Ozempic is not FDA-approved for weight loss, but may be prescribed off-label if a provider deems it appropriate
6 Months
$
first month
$
/month after
Quarterly
$
first month
$
/month after
Monthly
$
first month
$
/month after
Ozempic is a brand-name version of the generic medication semaglutide, which is a type of medication called a glucagon-like peptide 1 receptor agonist. Instead of that tongue-twister of a name, we call these medications “GLP-1s” for short.
Ozempic is FDA-approved for the management of certain symptoms and risks of type 2 diabetes.
Ozempic works by mimicking the hormone GLP-1, which helps regulate blood sugar levels and appetite. It stimulates insulin release when blood sugar levels are high and reduces the amount of glucose produced by the liver. Additionally, it slows down the rate at which food leaves the stomach, helping to control appetite and promote a feeling of fullness. This combination of effects can aid in weight loss and improve blood sugar control in individuals with type 2 diabetes.
All medications carry a risk of potential side effects. Ozempic’s side effects are typically mild and often improve within the first few weeks. When they occur, it’s usually when doses are increased, then tend to improve once a steady dose is reached. Some of the most common side effects include:
- Nausea
- Vomiting
- Upset stomach
- Stomach pains
- Constipation
- Diarrhea
- Heartburn
- Acid reflux
- Belching and gas
- Dizziness
- Headaches
- Fatigue
Lose up to 20% of your bodyweight
People lost an average of 14.9% (up to 20%) bodyweight in a 68-week clinical study of Wegovy® (semaglutide).
Lose up to 20% of your bodyweight
People lost an average of 14.9% (up to 20%) bodyweight in a 68-week clinical study of Wegovy® (semaglutide).
Lose up to 20% of your bodyweight
People lost an average of 14.9% (up to 20%) bodyweight in a 68-week clinical study of Wegovy® (semaglutide).
Why
Ozempic®
?

What is Ozempic®?
Ozempic® is a brand-name version of the generic medication semaglutide. It belongs to a class of medications called GLP-1 receptor agonists. These drugs are FDA-approved for managing certain symptoms and risks associated with type 2 diabetes.
%20(2).avif)







.avif)
.avif)
.avif)
.avif)






